This is the authors' abstract. We don't add key points for this paper.
(N,N' = 2-(2-dialkylaminopyrimidin-4-yl)pyrimidine) can undergo roll-over cyclometallation leading to a novel N,N'-donor site. Following this strategy heterobimetallic complexes including iridium(iii) and a Group X metal centre in the oxidation state +II were achieved.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Schön et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: